Steritas’ Pediatric Glucocorticoid Toxicity Index applied in clinical trial to assess steroid-toxicity

Steritas LLC., a company dedicated to enhancing patient care for steroid-treated patients announced that Alder Hey Children’s NHS Foundation Trust, and the Liverpool Clinical Trials Centre will apply its Steritas Pediatric Glucocorticoid Toxicity Index (pGTI) in a clinical trial to compare efficacy, safety and cost-effectiveness of intravenous versus oral glucocorticoids (steroids) for children and young people with Juvenile Idiopathic Arthritis (JIA).

Targeted use of ultrasound technology can lead to significant changes in brain function

The targeted use of ultrasound technology can bring about significant changes in brain function that could pave the way towards treatment of conditions such as

September 13, 2023

Pharma can’t let Big Tech win the race for medical AI

Five years from now, when patients walk into a doctor’s office presenting symptoms of almost any condition you can envision — whether migraine, multiple sclerosis,

July 3, 2023

Altered breathing in those without a sense of smell could explain health issues

Research shows individuals with anosmia have altered breathing patterns, linking smell loss to health issues and highlighting olfaction’s role in respiration.

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.